WeijieMaMD(He/Him)

PubMed

• 19 citations
  Squamous Cell Transformation of Primary Lung Adenocarcinoma in a Patient With EML4-ALK Fusion Variant 5 Refractory to ALK Inhibitors.
  Jay Gong, Jeffrey P. Gregg, Weijie Ma, Ken Y. Yoneda, Elizabeth H Moore, Megan E. Daly, Yanhong Zhang, Melissa J Williams, Tianhong Li> ;Journal of the National Comprehensive Cancer Network. 2019 Apr 1
• 4 citations
  Sortilin as a new membrane inhibitor of EGFR trafficking for overcoming resistance to EGFR inhibitors in non-small cell lung cancer
  Qianping Li, Weijie Ma, Tianhong Li> ;Journal of Thoracic Disease. 2018 Sep 1
• 3 citations
  Safety and Efficacy of Osimertinib in the Treatment of a Patient With Metastatic Lung Cancer and Concurrent Somatic EGFR L858R and Germline EGFR T790M Mutations
  Weijie Ma, Jay Gong, Jidong Shan, Debbie A. Lewis, Wenwu Xiao, Elizabeth H Moore, Yanhong Zhang, Jamie Hung, Nicole Mans, Sixi Wei, Jenna Welborn, Nicholas S. Stollenw...> ;JCO Precision Oncology. 2018 Aug 14
• 1 citations
  Labyrinthin Expression Is Associated with Poor Prognosis in Patients with Non-Small-Cell Lung Cancer.
  Weijie Ma, Jie Zeng, Dennis J Montoya, Kyra Toomey, Chihong Zhou, Shuai Chen, Dingning Liu, Michael Babich, James A Radosevich, Tianhong Li> ;Cancers. 2023 Feb 1
• 26 citations
  Increasing cure rates of solid tumors by immune checkpoint inhibitors.
  Weijie Ma, Ruobing Xue, Zheng Zhu, Hizra Farrukh, Wenru Song, Tianhong Li, Lei Zheng, Chong-Xian Pan> ;Experimental Hematology & Oncology. 2023 Jan 16
• 2 citations
  Dynamic evaluation of blood immune cells predictive of response to immune checkpoint inhibitors in NSCLC by multicolor spectrum flow cytometry.
  Sixi Wei, Siqi Long, Eddie C Tian, Bridget McLaughlin, Maria Jaimes, Dennis J Montoya, Varun R Viswanath, Jeremy Chien, Qianjun Zhang, Jonathan E Van Dyke, Shuai Chen,...> ;Frontiers in Immunology. 2023 Jan 1
• Hospitalized cancer patients with comorbidities and low lymphocyte counts had poor clinical outcomes to immune checkpoint inhibitors.
  Richard Benjamin Young, Hemali Panchal, Shuai Chen, Aaron Steele, Andrea Iannucci, Tianhong Li, Ma, W., Weijie Ma> ;Frontiers in Oncology. 2022 Jan 1
• 26 citations
  Cancer neoantigens as potential targets for immunotherapy.
  Weijie Ma, Brian Pham, Tianhong Li> ;Clinical & Experimental Metastasis. 2021 May 5
• 11 citations
  Giant Magnetoresistive Nanosensor Analysis of Circulating Tumor DNA Epidermal Growth Factor Receptor Mutations for Diagnosis and Therapy Response Monitoring
  Jared C. Nesvet, Katie A. Antilla, Danielle S. Pancirer, Alexander X. Lozano, Jordan S. Preiss, Aihua Fu, Seung-min Park, Sanjiv S. Gambhir, Alice C. Fan, Joel W. Neal...> ;Clinical Chemistry. 2021 Mar 1
• 9 citations
  High integrin α3 expression is associated with poor prognosis in patients with non-small cell lung cancer.
  Qianping Li, Shuai Chen, Eddie C. Tian, Sixi Wei, Reggie R. Fan, Tao Wang, Chihong Zhou, Tianhong Li, Ma, W., Weijie Ma> ;Translational Lung Cancer Research. 2020 Jul 8
• 4 citations
  Emerging EML4-ALK Variant 5 as a Concurrent Resistance Mechanism to Osimertinib in a Patient With EGFR E19del/T790M NSCLC
  Yan Yan, Guozhong Jiang, Weijie Ma, Tianhong Li, Liping Wang> ;Clinical Lung Cancer. 2020 May 16
• 13 citations
  Translational Biomarkers and Rationale Strategies to Overcome Resistance to Immune Checkpoint Inhibitors in Solid Tumors.
  Justin A. Chen, Jianda Yuan, Tianhong Li, Ma, W., Weijie Ma> ;Cancer Treatment and Research. 2020 Jan 1
• 3 citations
  Correction to: High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer
  Wenwu Xiao, Sixi Wei, Qianping Li, Ruiwu Liu, Randy P. Carney, Kevin Yang, Joyce S Lee, Alan Nyugen, Ken Y. Yoneda, Kit S. Lam, Tianhong Li, Ma, W., Weijie Ma> ;Journal of Hematology & Oncology. 2019 Jul 26
• 27 citations
  High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer
  Wenwu Xiao, Weijie Ma, Sixi Wei, Qianping Li, Ruiwu Liu, Randy P. Carney, Kevin Yang, Joyce S Lee, Alan Nyugen, Ken Y. Yoneda, Kit S. Lam, Tianhong Li> ;Journal of Hematology & Oncology. 2019 Jun 10
• 9 citations
  Ensartinib (X-396): what does it add for patients with ALK-rearranged NSCLC.
  Tianhong Li, Weijie Ma, Eddie C. Tian> ;Chinese Clinical Oncology. 2019 Oct 1
• 24 citations
  Clinical utility of tumor genomic profiling in patients with high plasma circulating tumor DNA burden or metabolically active tumors
  Cathy Zhou, Zilong Yuan, Weijie Ma, Lihong Qi, Angelique Mahavongtrakul, Ying Li, Hong Li, Jay Gong, Reggie R. Fan, Jin Li, Michael Molmen, Travis A. Clark, Dean Pavli...> ;Journal of Hematology & Oncology. 2018 Nov 6
• 27 citations
  Severe nivolumab-induced pneumonitis preceding durable clinical remission in a patient with refractory, metastatic lung squamous cell cancer: a case report
  Hong Li, Weijie Ma, Ken Y. Yoneda, Elizabeth H Moore, Yanhong Zhang, Lee Li-Qun Pu, Garrett M. Frampton, Michael Molmen, Philip J. Stephens, Tianhong Li> ;Journal of Hematology & Oncology. 2017 Feb 28
• 297 citations
  Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy.
  Weijie Ma, Barbara M. Gilligan, Jianda Yuan, Tianhong Li> ;Journal of Hematology & Oncology. 2016 May 27
• 10 citations
  Reduced expression of Slit2 in renal cell carcinoma
  Wei-Jie Ma, Yu Zhou, Dan Lu, Dong Dong, Xiao-Jun Tian, Jie-xi Wen, Jun Zhang> ;Medical Oncology. 2014 Jan 1
• Join now to see all

Journal Articles

• Durable clinical response to the multidisciplinary management of neurosurgery, radiation and chemoimmunotherapy in a patient with PD-L1/PD-L2/JAK2 (PDJ)-amplified, ref...  
  Hongyuan Zhao, Weijie Ma, Ruben C Fragoso, Griffith R Harsh IV, Arya Ashok, Tianhong Li, Journal of the National Cancer Center, 9/1/2021
• Targeting HER2 genomic alterations in non-small cell lung cancer  
  Jie Zeng, Weijie Ma, Richard Benjamin Young, Tianhong Li, Journal of the National Cancer Center, 6/1/2021

Books/Book Chapters

• Advanced Pharmacology for Prescribers 
  Chapter: 26: Hematology/Oncology and Supportive Care for the Nononcologist 
  Li, Tianhong | Ma, Weijie | Feng, Xiaodong2021
• Handbook of Therapeutic Biomarkers in Cancer 
  Chapter: Biomarkers for the Immune Checkpoint Inhibitors 
  Weijie Ma, Sixi Wei, Eddie C. Tian, Tianhong LiJenny Stanford Publishing2021